SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-300047
Filing Date
2021-10-15
Accepted
2021-10-15 16:17:01
Documents
19
Period of Report
2021-10-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d228298d8k.htm   iXBRL 8-K 31014
2 EX-1.1 d228298dex11.htm EX-1.1 208189
3 EX-5.1 d228298dex51.htm EX-5.1 6765
4 EX-99.1 d228298dex991.htm EX-99.1 7223
5 EX-99.2 d228298dex992.htm EX-99.2 7960
6 EX-99.3 d228298dex993.htm EX-99.3 8417
10 GRAPHIC g228298dsp37logo.jpg GRAPHIC 3567
11 GRAPHIC g228298sareptabanner.jpg GRAPHIC 8205
  Complete submission text file 0001193125-21-300047.txt   482416

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA srpt-20211012.xsd EX-101.SCH 2926
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE srpt-20211012_lab.xml EX-101.LAB 18140
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srpt-20211012_pre.xml EX-101.PRE 11431
12 EXTRACTED XBRL INSTANCE DOCUMENT d228298d8k_htm.xml XML 3360
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 211326258
SIC: 2834 Pharmaceutical Preparations